Analyst Presentation (Q2 FY17)
ICRA Ltd has informed BSE regarding "Submission of Analyst Presentation (Q2 FY17)".04-11-2016
04-11-2016
Announces Q2 results (Standalone & Consolidated), Limited Review Report (Standalone & Consolidated) and Results Press Release for the Quarter ended September 30, 2016
ICRA Ltd has announced the following results for the quarter ended September 30, 2016:The Unaudited Standalone results for the Quarter ended September 30, 2016The Company has posted a net profit of Rs. 191.478 million for the quarter ended September 30, 2016 as compared to Rs. 191.149 million for the quarter ended September 30, 2015. Total Income has increased from Rs. 568.862 million for the quarter ended September 30, 2015 to Rs....03-11-2016
Outlook on the Indian footwear sector negative: ICRA
Indian domestic footwear companies have also witnessed pressure on sales volumes in the recent quarters due to weak consumer sentiment.03-11-2016
Intimation of schedule of Earnings Conference Call
ICRA Ltd has informed BSE regarding "Intimation of schedule of Earnings Conference Call".02-11-2016
Drug Price Control Order continues to drag growth of pharma industry
ICRA expects the DPCO segment of IPM to grow at 1-3 per cent for FY17 while the overall IPM will grow at 10-12 per cent22-10-2016
ICRA retains negative outlook on telcos on rising debt levels
Rating agency ICRA on Wednesday said the recently concluded spectrum auctions will push up operators' debt to 4.25-lakh crore , and retained its negative outlook on the sector. We continue to...19-10-2016
ICRA downgrades Amtek Auto unit's term loan rating
The rating action also takes into account the continued depressed financial performance16-10-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
ICRA Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.16-10-2016
Credit quality improvement still not on horizon: ICRA
He noted strengthening in credit quality of sectors like pharma and IT is not imminent in backdrop of increasing regulatory intervention and slowing client spending overseas.10-10-2016
Update on Sale of ICTEAS
With reference to the earlier letters dates August 05, 2016 & September 19, 2016, ICRA Ltd has now informed BSE that the Company has received the purchase consideration and delivered the shares held in physical form and delivery instruction slip for transfer of shares held in dematerialised form, on October 07, 2016.08-10-2016